[
  {
    "title": "欧林生物(688319.SH)：获得政府补助1426.8万元",
    "href": "http://stock.jrj.com.cn/2022/12/30154737249623.shtml",
    "datetime": "2022-12-30 15:47:40",
    "code": "688319"
  },
  {
    "title": "欧林生物(688319.SH)：张渝完成减持0.5149%股份",
    "href": "http://stock.jrj.com.cn/2022/12/30154637249627.shtml",
    "datetime": "2022-12-30 15:46:23",
    "code": "688319"
  },
  {
    "title": "欧林生物(688319.SH)：1-11月累获政府补助1209.91万元",
    "href": "http://stock.jrj.com.cn/2022/12/01154237181418.shtml",
    "datetime": "2022-12-01 15:42:00",
    "code": "688319"
  },
  {
    "title": "欧林生物2022年前三季度净利4017.65万同比下滑48.27% 研发费用增加",
    "href": "http://stock.jrj.com.cn/2022/10/29121137096600.shtml",
    "datetime": "2022-10-29 12:11:52",
    "code": "688319"
  },
  {
    "title": "欧林生物(688319.SH)：第三季度净利降74.14%至913.41万元",
    "href": "http://stock.jrj.com.cn/2022/10/28191537095033.shtml",
    "datetime": "2022-10-28 19:15:08",
    "code": "688319"
  },
  {
    "title": "欧林生物(688319.SH)：泰昌集团质押600万股",
    "href": "http://stock.jrj.com.cn/2022/10/18165437064274.shtml",
    "datetime": "2022-10-18 16:54:14",
    "code": "688319"
  },
  {
    "title": "欧林生物(688319.SH)：股东张渝减持期过半 累计减持0.49%股份",
    "href": "http://stock.jrj.com.cn/2022/10/09161337041624.shtml",
    "datetime": "2022-10-09 16:13:57",
    "code": "688319"
  },
  {
    "title": "欧林生物(688319.SH)：重组金黄色葡萄球菌疫苗(大肠杆菌)III期临床试验完成首例受试者接种",
    "href": "http://stock.jrj.com.cn/2022/08/31174736958759.shtml",
    "datetime": "2022-08-31 17:47:27",
    "code": "688319"
  },
  {
    "title": "欧林生物2022年上半年净利3104.24万同比减少26.71% 研发费用增加",
    "href": "http://stock.jrj.com.cn/2022/08/17215136909695.shtml",
    "datetime": "2022-08-17 21:51:56",
    "code": "688319"
  },
  {
    "title": "欧林生物(688319.SH)：上半年净利润降26.71%至3104.24万元",
    "href": "http://stock.jrj.com.cn/2022/08/17182236908908.shtml",
    "datetime": "2022-08-17 18:22:07",
    "code": "688319"
  },
  {
    "title": "欧林生物（688319）：于公司会议室举行投资者关系活动",
    "href": "http://stock.jrj.com.cn/2022/08/05091636872587.shtml",
    "datetime": "2022-08-05 09:16:50",
    "code": "688319"
  },
  {
    "title": "欧林生物(688319.SH)：股东张渝拟减持不超1%股份",
    "href": "http://stock.jrj.com.cn/2022/06/20163836743045.shtml",
    "datetime": "2022-06-20 16:38:32",
    "code": "688319"
  },
  {
    "title": "高管调整风波答疑来了，欧林生物回复上交所针对聘任高管事项问询",
    "href": "http://stock.jrj.com.cn/2022/06/13105436723273.shtml",
    "datetime": "2022-06-13 10:54:43",
    "code": "688319"
  },
  {
    "title": "超半数限售股即将迎来解禁，欧林生物高管变动遭上交所问询",
    "href": "http://stock.jrj.com.cn/2022/06/02102336699465.shtml",
    "datetime": "2022-06-02 10:23:50",
    "code": "688319"
  },
  {
    "title": "欧林生物聘任樊绍文为公司总经理 2021年度公司净利4235.35万",
    "href": "http://stock.jrj.com.cn/2022/06/01215036698454.shtml",
    "datetime": "2022-06-01 21:50:52",
    "code": "688319"
  },
  {
    "title": "欧林生物(688319)首次公开发行部分限售股于2022年6月8日上市流通",
    "href": "http://stock.jrj.com.cn/2022/05/31082936691762.shtml",
    "datetime": "2022-05-31 08:29:50",
    "code": "688319"
  },
  {
    "title": "欧林生物(688319.SH)：2.52亿股限售股将于6月8日解禁上市",
    "href": "http://stock.jrj.com.cn/2022/05/30164936689866.shtml",
    "datetime": "2022-05-30 16:49:05",
    "code": "688319"
  },
  {
    "title": "欧林生物选举樊绍文担任公司董事长 2021年度公司净利1.08亿",
    "href": "http://stock.jrj.com.cn/2022/05/19201036663443.shtml",
    "datetime": "2022-05-19 20:10:55",
    "code": "688319"
  },
  {
    "title": "欧林生物(688319.SH)：b型流感嗜血杆菌结合疫苗获得药品再注册批准通知书",
    "href": "http://stock.jrj.com.cn/2022/05/06171836581568.shtml",
    "datetime": "2022-05-06 17:18:12",
    "code": "688319"
  },
  {
    "title": "欧林生物2021年净利1.08亿同比增长198.82% 董事长樊绍文薪酬120.13万",
    "href": "http://stock.jrj.com.cn/2022/05/04085036552517.shtml",
    "datetime": "2022-05-04 08:50:43",
    "code": "688319"
  },
  {
    "title": "欧林生物2022年第一季度亏损680.52万 研发费用上升",
    "href": "http://stock.jrj.com.cn/2022/05/03191136546528.shtml",
    "datetime": "2022-05-03 19:11:46",
    "code": "688319"
  },
  {
    "title": "止盈转亏 欧林生物2022年一季度净亏损680.52万元",
    "href": "http://stock.jrj.com.cn/2022/04/28085836490287.shtml",
    "datetime": "2022-04-28 08:58:32",
    "code": "688319"
  },
  {
    "title": "欧林生物披露2021年年报 实现营收4.87亿元",
    "href": "http://stock.jrj.com.cn/2022/04/28085836490291.shtml",
    "datetime": "2022-04-28 08:58:01",
    "code": "688319"
  },
  {
    "title": "欧林生物(688319.SH)：拟在成都天府国际生物城投建新诺明疫苗研发和产业转化共享服务型研究院项目",
    "href": "http://stock.jrj.com.cn/2022/03/08181534541994.shtml",
    "datetime": "2022-03-08 18:15:50",
    "code": "688319"
  },
  {
    "title": "欧林生物2021年净利1.11亿同比增长206.18% 吸附破伤风疫苗销售持续增长",
    "href": "http://stock.jrj.com.cn/2022/02/22183034435416.shtml",
    "datetime": "2022-02-22 18:30:07",
    "code": "688319"
  },
  {
    "title": "欧林生物(688319.SH)业绩快报：2021年度归母净利增206.18%至1.11亿元",
    "href": "http://stock.jrj.com.cn/2022/02/22161534434632.shtml",
    "datetime": "2022-02-22 16:15:36",
    "code": "688319"
  },
  {
    "title": "欧林生物2021年预计净利1亿-1.15亿 同比增长177%-218% 产品销量增长",
    "href": "http://stock.jrj.com.cn/2022/01/25201234213842.shtml",
    "datetime": "2022-01-25 20:12:13",
    "code": "688319"
  },
  {
    "title": "欧林生物(688319.SH)：2021年度净利预增176.78%-218.29%",
    "href": "http://stock.jrj.com.cn/2022/01/25170434212643.shtml",
    "datetime": "2022-01-25 17:04:24",
    "code": "688319"
  },
  {
    "title": "欧林生物股东泰昌集团质押600万股 用于融资担保",
    "href": "http://stock.jrj.com.cn/2022/01/24231234206963.shtml",
    "datetime": "2022-01-24 23:12:04",
    "code": "688319"
  },
  {
    "title": "欧林生物(688319.SH)：收到重组金黄色葡萄球菌疫苗(大肠杆菌)II期临床试验总结报告",
    "href": "http://stock.jrj.com.cn/2021/12/30160934086889.shtml",
    "datetime": "2021-12-30 16:09:23",
    "code": "688319"
  },
  {
    "title": "欧林生物(688319.SH)：169.337万股限售股将于12月8日解禁上市",
    "href": "http://stock.jrj.com.cn/2021/11/29163633938241.shtml",
    "datetime": "2021-11-29 16:36:40",
    "code": "688319"
  },
  {
    "title": "欧林生物：前三季度净利润7767.24万元，同比增长114.99%",
    "href": "http://stock.jrj.com.cn/2021/10/31223733785505.shtml",
    "datetime": "2021-10-31 22:37:16",
    "code": "688319"
  },
  {
    "title": "欧林生物(688319.SH)：第三季度净利增52.89%至3531.89万元",
    "href": "http://stock.jrj.com.cn/2021/10/29160633777448.shtml",
    "datetime": "2021-10-29 16:06:46",
    "code": "688319"
  },
  {
    "title": "欧林生物(688319.SH)：累计获得政府补助410万元",
    "href": "http://stock.jrj.com.cn/2021/09/30153933542945.shtml",
    "datetime": "2021-09-30 15:39:08",
    "code": "688319"
  },
  {
    "title": "欧林生物(688319.SH)：吸附破伤风疫苗获得药品再注册批准通知书",
    "href": "http://stock.jrj.com.cn/2021/09/23161133504777.shtml",
    "datetime": "2021-09-23 16:11:23",
    "code": "688319"
  },
  {
    "title": "欧林生物(688319.SH)：向86名激励对象授予32万股限制性股票",
    "href": "http://stock.jrj.com.cn/2021/09/15160933439826.shtml",
    "datetime": "2021-09-15 16:09:08",
    "code": "688319"
  },
  {
    "title": "欧林生物副总经理马恒军增持20.91万股 耗资606.06万 上半年公司净利4235.35万",
    "href": "http://stock.jrj.com.cn/2021/08/30213133355363.shtml",
    "datetime": "2021-08-30 21:31:41",
    "code": "688319"
  },
  {
    "title": "欧林生物(688319.SH)：拟推2021年限制性股票激励计划",
    "href": "http://stock.jrj.com.cn/2021/08/24210833311943.shtml",
    "datetime": "2021-08-24 21:08:59",
    "code": "688319"
  },
  {
    "title": "欧林生物2021年半年度净利4235.35万元 同比净利增加225.11%",
    "href": "http://stock.jrj.com.cn/2021/08/24201533311687.shtml",
    "datetime": "2021-08-24 20:15:19",
    "code": "688319"
  },
  {
    "title": "欧林生物(688319.SH)：上半年净利增225.11%至4235.35万元",
    "href": "http://stock.jrj.com.cn/2021/08/24190033311282.shtml",
    "datetime": "2021-08-24 19:00:25",
    "code": "688319"
  },
  {
    "title": "欧林生物(688319.SH)：累计获得政府补助406.69万元",
    "href": "http://stock.jrj.com.cn/2021/07/12172133083277.shtml",
    "datetime": "2021-07-12 17:21:02",
    "code": "688319"
  },
  {
    "title": "欧林生物实际控制人樊绍文增持29.28万股 耗资1103.67万",
    "href": "http://stock.jrj.com.cn/2021/07/07205333060273.shtml",
    "datetime": "2021-07-07 20:53:14",
    "code": "688319"
  },
  {
    "title": "欧林生物(688319.SH)：实控人樊绍文累计增持29.28万股 增持计划实施完毕",
    "href": "http://stock.jrj.com.cn/2021/07/07161333058496.shtml",
    "datetime": "2021-07-07 16:13:26",
    "code": "688319"
  },
  {
    "title": "A股异动 | 欧林生物(688319.SH)涨13% 实控人及公司高管拟增持股份",
    "href": "http://stock.jrj.com.cn/2021/06/28093933008496.shtml",
    "datetime": "2021-06-28 09:39:26",
    "code": "688319"
  },
  {
    "title": "欧林生物(688319.SH)：实控人及高管拟增持股份 合计增持金额不超3200万元",
    "href": "http://stock.jrj.com.cn/2021/06/25164532996879.shtml",
    "datetime": "2021-06-25 16:45:25",
    "code": "688319"
  },
  {
    "title": "欧林生物上市首日涨304% IPO募4亿英大证券赚0.3亿",
    "href": "http://stock.jrj.com.cn/2021/06/08153332893403.shtml",
    "datetime": "2021-06-08 15:33:00",
    "code": "688319"
  },
  {
    "title": "欧林生物：将于2021年6月8日在上海证券交易所科创板科创板上市",
    "href": "http://stock.jrj.com.cn/2021/06/07073632885239.shtml",
    "datetime": "2021-06-07 07:36:56",
    "code": "688319"
  },
  {
    "title": "欧林生物(688319.SH)：回拨后网上发行的中签率为0.03088370%",
    "href": "http://stock.jrj.com.cn/2021/05/27214032832083.shtml",
    "datetime": "2021-05-27 21:40:20",
    "code": "688319"
  },
  {
    "title": "今日申购：呈和科技、欧林生物、迈拓股份",
    "href": "http://stock.jrj.com.cn/2021/05/27090232827407.shtml",
    "datetime": "2021-05-27 09:02:00",
    "code": "688319"
  },
  {
    "title": "欧林生物(688319.SH)：IPO定价9.88元/股 5月27日开启申购",
    "href": "http://stock.jrj.com.cn/2021/05/25215232818700.shtml",
    "datetime": "2021-05-25 21:52:27",
    "code": "688319"
  },
  {
    "title": "欧林生物(688319.SH)：网上路演时间5月26日9:00-12:00",
    "href": "http://stock.jrj.com.cn/2021/05/24191832811985.shtml",
    "datetime": "2021-05-24 19:18:00",
    "code": "688319"
  },
  {
    "title": "同意注册！煜邦电力、西安凯立、呈和科技、欧林生物、纳微科技科创板IPO再进一步",
    "href": "http://stock.jrj.com.cn/2021/04/22103332421796.shtml",
    "datetime": "2021-04-22 10:33:19",
    "code": "688319"
  },
  {
    "title": "证监会同意煜邦电力、西安凯立、呈和科技、欧林生物、纳微科技科创板IPO注册",
    "href": "http://stock.jrj.com.cn/2021/04/21201332418419.shtml",
    "datetime": "2021-04-21 20:13:00",
    "code": "688319"
  },
  {
    "title": "康拓医疗科创板IPO提交注册 欧林生物中止审核情形消除",
    "href": "http://stock.jrj.com.cn/2021/04/13103732363359.shtml",
    "datetime": "2021-04-13 10:37:19",
    "code": "688319"
  },
  {
    "title": "蓝箭电子、铁建重工、欧林生物、和辉光电、三孚新科、奥精医疗科创板IPO提交注册",
    "href": "http://stock.jrj.com.cn/2021/03/05092332076242.shtml",
    "datetime": "2021-03-05 09:23:40",
    "code": "688319"
  },
  {
    "title": "欧林生物IPO：研发不足还一直亏损 行贿或助利益输送",
    "href": "http://stock.jrj.com.cn/2021/03/05075632091620.shtml",
    "datetime": "2021-03-05 07:56:00",
    "code": "688319"
  },
  {
    "title": "欧林生物过会：今年IPO过关第14家 英大证券过首单",
    "href": "http://stock.jrj.com.cn/2021/01/08104131653774.shtml",
    "datetime": "2021-01-08 10:41:00",
    "code": "688319"
  },
  {
    "title": "新年第二波！欧林生物、铁建重工将于1月7日科创板上会受审",
    "href": "http://stock.jrj.com.cn/2020/12/31115831611459.shtml",
    "datetime": "2020-12-31 11:58:07",
    "code": "688319"
  },
  {
    "title": "欧林生物、铁建重工将于2021年1月7日科创板首发上会",
    "href": "http://stock.jrj.com.cn/2020/12/30203831606742.shtml",
    "datetime": "2020-12-30 20:38:00",
    "code": "688319"
  },
  {
    "title": "销售费用率偏高 欧林生物拟募资超7亿元冲刺科创板IPO | 产业新股",
    "href": "http://stock.jrj.com.cn/2020/09/29171130860464.shtml",
    "datetime": "2020-09-29 17:11:48",
    "code": "688319"
  },
  {
    "title": "欧林生物与陆军军医大学联合开展新冠肺炎疫苗研发",
    "href": "http://stock.jrj.com.cn/2020/02/23223328877351.shtml",
    "datetime": "2020-02-23 22:33:03",
    "code": "688319"
  },
  {
    "title": "欧林生物脑膜炎疫苗获国家食药监局优先审评",
    "href": "http://stock.jrj.com.cn/2018/05/03175024488217.shtml",
    "datetime": "2018-05-03 17:50:40",
    "code": "688319"
  },
  {
    "title": "欧林生物2017年营收4465万元 净赚68万元",
    "href": "http://stock.jrj.com.cn/2018/05/02165924481361.shtml",
    "datetime": "2018-05-02 16:59:00",
    "code": "688319"
  },
  {
    "title": "欧林生物或成川企“新三板+H股”第一股",
    "href": "http://stock.jrj.com.cn/2018/04/24002624436743.shtml",
    "datetime": "2018-04-24 00:26:31",
    "code": "688319"
  }
]